Diabetes mellitus Posts on Medivizor
Navigation Menu

Diabetes mellitus Posts on Medivizor

Predicting the Risk of Getting Type 2 Diabetes: How do they know?

Predicting the Risk of Getting Type 2 Diabetes: How do they know?

Posted by on Sep 30, 2022 in Blog, Diabetes mellitus | 0 comments

Are you ever skeptical when you see drug claims? One of my first questions when I read about a new drug or a statistic of some kind is: How do they know that? When I read about two new weight loss drugs presented at the European Association for the Study of Diabetes (EASD) in Stockholm, Sweden (19-23 Sept), my antennae went up. Here’s the story. Drug...

Read More

Evaluating the long-term effects of non-pharmacological interventions on diabetes and chronic complication outcomes in patients with high blood glucose levels.

Evaluating the long-term effects of non-pharmacological interventions on diabetes and chronic complication outcomes in patients with high blood glucose levels.

Posted by on Sep 20, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the long-term effects of non-pharmacological (non-drug) interventions on diabetes and chronic complication outcomes in patients with high blood glucose (hyperglycemia) levels. The data showed that non-pharmacological interventions have a long-term effect on reducing diabetes occurrence among prediabetic patients...

Read More

Evaluating the effectiveness of laser photocoagulation plus anti-VEGF treatment in patients with diabetic eye disease.

Evaluating the effectiveness of laser photocoagulation plus anti-VEGF treatment in patients with diabetic eye disease.

Posted by on Sep 18, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the effectiveness of panretinal photocoagulation (PRP) plus intravitreal anti-VEGF treatment versus PRP alone for the treatment of patients with diabetic retinopathy (DR; diabetic eye disease). The data showed that PRP with anti-VEGF combination treatment improved vision without an increase in side effects...

Read More

Evaluating the long-term effects of a moderate low-carbohydrate diet on blood glucose control and liver function in patients with type 2 diabetes

Evaluating the long-term effects of a moderate low-carbohydrate diet on blood glucose control and liver function in patients with type 2 diabetes

Posted by on Sep 17, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the long-term effects of a moderate low-carbohydrate diet (LCD) on blood glucose control and liver function in patients with type 2 diabetes (T2D). The data showed that patients on a moderate LCD diet showed better blood glucose control and liver function over the long term than patients on a traditional diabetic...

Read More

Evaluating the effectiveness and safety of eplerenone treatment for patients with diabetic kidney disease.

Evaluating the effectiveness and safety of eplerenone treatment for patients with diabetic kidney disease.

Posted by on Sep 11, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study assessed the effectiveness and safety of eplerenone (Inspra) treatment for diabetic nephropathy (DN; diabetic kidney disease) in patients with type 2 diabetes (T2D). The data showed that eplerenone can be an effective supplement to existing clinical treatment in patients with DN. Some background DN is kidney damage...

Read More

Can teneligliptin be safely and effectively given to patients with inadequately controlled type 2 diabetes by triple oral antidiabetic drug treatment?

Can teneligliptin be safely and effectively given to patients with inadequately controlled type 2 diabetes by triple oral antidiabetic drug treatment?

Posted by on Sep 11, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study compared the effectiveness and safety of teneligliptin (Tenelia) to placebo in patients with type 2 diabetes (T2D) that was inadequately controlled with triple oral antidiabetic drugs (OADs). The study showed that teneligliptin may be considered as a fourth add-on OAD treatment in these patients. Some background T2D is...

Read More

Evaluating the effectiveness, durability, and safety of faricimab in patients with diabetic macular edema.

Evaluating the effectiveness, durability, and safety of faricimab in patients with diabetic macular edema.

Posted by on Jul 16, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the effectiveness, durability, and safety of faricimab (Vabysmo) for the treatment of patients with diabetic macular edema (DME). The data showed that faricimab with extended dosing up to every 16 weeks was safe and showed good vision gains and clinical improvements in these patients. Some background...

Read More

Comparing the effects of a ketogenic diet app versus a calorie restricted, low-fat diet on weight loss in patients with overweight or obesity.

Comparing the effects of a ketogenic diet app versus a calorie restricted, low-fat diet on weight loss in patients with overweight or obesity.

Posted by on Jun 26, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study compared the effects of a ketogenic diet mobile health application (Keyto app) with breath acetone biofeedback (device) versus a calorie-restricted, low-fat diet (WW; weight watchers) app on weight loss and metabolic risk in patients with overweight or obesity. The data showed that a ketogenic diet app with a breath acetone...

Read More

Can canagliflozin improve insulin resistance and internal fat tissue in patients with type 2 diabetes better than metformin?

Can canagliflozin improve insulin resistance and internal fat tissue in patients with type 2 diabetes better than metformin?

Posted by on May 31, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study assessed the effects of canagliflozin (Invokana) therapy on body composition, glucose control, insulin resistance, and systemic (whole body) inflammation in patients with newly-diagnosed type 2 diabetes (T2D) compared to metformin (Glucophage). The data showed that canagliflozin therapy reduced visceral fat tissue, and...

Read More

Does diabetes affect lower urinary tract symptoms in patients with benign prostatic hyperplasia?

Does diabetes affect lower urinary tract symptoms in patients with benign prostatic hyperplasia?

Posted by on May 31, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study reviewed the effect of diabetes on lower urinary tract symptoms (LUTS) in patients with benign prostatic hyperplasia (BPH). The data suggested that LUTS were increased in patients with BPH that had diabetes compared to patients without diabetes. Some background Men above 50 years of age frequently experience LUTS due to...

Read More

Can a low-carbohydrate diet affect insulin-resistant lipoprotein metabolism?

Can a low-carbohydrate diet affect insulin-resistant lipoprotein metabolism?

Posted by on May 31, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study determined the effect of varying carbohydrate and saturated fat dietary contents on cardiovascular disease (CVD) risk factors during weight-loss maintenance. The authors concluded that restriction of carbohydrates provided improved insulin resistance on lipoprotein metabolism, without unwanted side effects on low-density...

Read More

Can a ketogenic diet affect patients newly diagnosed with type 2 diabetes that are obese or overweight?

Can a ketogenic diet affect patients newly diagnosed with type 2 diabetes that are obese or overweight?

Posted by on May 31, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study observed the effectiveness of a ketogenic diet (KD) in patients newly diagnosed with type 2 diabetes (T2D) that were overweight or obese. The authors concluded that a DK can control body weight, blood glucose, and blood lipids (fats) in these patients but long-term adherence is a challenge. Some background...

Read More